EIF eiffel technologies limited

opportunity for 500% increase

  1. 5,890 Posts.
    lightbulb Created with Sketch. 1869
    EIF in conjuction with www.map.com.
    Map pharmecueticals ,will be conducting human trials
    regarding inhaled insulin and an improved asthma delivery system using eiffeltechnology nano particles.
    map pharmecueticals have recieved a US 25 Million dollars grant.
    Also inhaled insulin has been approved in Europe, matter of time that EIF AND MAP capture the US market.
    At these prices excellent entry point.One to put on
    your watch list.
    Have been involved with EIF for along time.
 
watchlist Created with Sketch. Add EIF (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.